Effect of ω-3 and ω-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Comba, Andrea ^a,b   Maestri, Damian M ^a,b   Berra, María A ^a   Garcia, Carolina Paola ^a   Das, Undurti N ^c,d,e   Eynard, Aldo R ^a,b   Pasqualini, María E ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^d UND LIFE SCIENCES   (United States)

^e KRISHNA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

12 LIPOOXYGENASE; 15 LIPOOXYGENASE 1; 15 LIPOOXYGENASE 2; ARACHIDONIC ACID; ARACHIS OIL; FATTY ACID; LIPOXYGENASE; OMEGA 3 FATTY ACID; OMEGA 9 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; ARACHIDONATE LIPOXYGENASE; UNSATURATED FATTY ACID; VEGETABLE OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIPID COMPOSITION; LYMPHOCYTIC INFILTRATION; MALE; METASTASIS; MITOSIS; MOUSE; NONHUMAN; NUTRITION; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; EXPERIMENTAL NEOPLASM; METABOLISM; MORTALITY; NUT; PATHOLOGY; PEANUT; RANDOMIZATION; WALNUT;

ARACHIS HYPOGAEA; JUGLANS; MURINAE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; ARACHIDONATE LIPOXYGENASES; ARACHIS HYPOGAEA; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; JUGLANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MITOSIS; NEOPLASM TRANSPLANTATION; NUTS; PLANT OILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RANDOM ALLOCATION; TUMOR BURDEN;

EID: 77957608027     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-112     Document Type: Article

References (47)

1. International Agency for Research on Cancer. Globocan 2008, Lyon 2008 http://www-dep.iarc.fr/
2. Role of hormonal and environmental factors on early incidence of breast cancer in Iran. SA Bidgoli R Ahmadi MD Zavarhei, Scie Total Enviorn 2010 408 4056 4061 10.1016/j.scitotenv.2010.05.018
3. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. AC Thiébaut V Chajès M Gerber MC Boutron-Ruault V Joulin G Lenoir F Berrino E Riboli J Bénichou F Clavel-Chapelon, Int J Cancer 2009 124 924 931 10.1002/ijc.23980 19035453
4. Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids. IA Shaikh I Brown KW Wahle SD Heys, Nutr Cancer 2010 62 284 96 10.1080/01635580903407189 20358465
5. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. CAC Hyde S Missailidis, Intern Immunoph 2009 9 701 715 10.1016/j.intimp.2009.02.003
6. Primers on Molecular Pathways - Lipoxygenases: Their Role as an Oncogenic Pathway in Pancreatic Cancer. A Comba ME Pasqualini, Pancreatology 2009 9 724 728 10.1159/000235623 20016244
7. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. JJ Moreno, Biochem Pharmacol 2009 77 1 10 10.1016/j.bcp.2008.07.033 18761324
8. Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. UN Das, Nutrition
9. Tumour cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. R Zeidler M Csanady O Gires S Lang B Schmitt B Wollenberg, FASEB J 2000 17 661 668
10. Effect of the Extraction and Bleaching-Processes on Jojoba (Simmondsia chinensis) Wax Quality. L Tobares C Guzmn DM Maestri, Eur J Lipid Sci Technol 2003 105 749 753 10.1002/ejlt.200300841 (Pubitemid 38073058)
11. Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior. S Galli MI Labato E Bal de Kier Joffé MC Carreras JJ Poderoso, Cancer Res 2003 63 6370 6377 14559826
12. Effect of Chia Oil (Salvia Hispanica) rich in n-3 fatty acids on the eicosanoid release, apoptosis and T-lymphocyte tumour infiltration in a murine mammary gland. CE Espada MA Berra MJ Martinez AR Eynard ME Pasqualini, Prost Leukot Essent Fatty Acids 2007 77 21 28 10.1016/j.plefa.2007.05.005 (Pubitemid 47260678)
13. A comparative study of seed lipid components of Nicotianeae (Solanaceae). DM Maestri CA Guzmn, Biochem Syst Ecl 1995 23 201 207 10.1016/0305-1978(95) 93850-3
14. Fatty acids specifically related to the anisotropic properties of plasma membrane from rat urothelium. RO Calderán AR Eynard, Biochim Biophys Acta 2000 1483 174 84 10601706
15. Prostate tumour growth can be modulated by dietary targeting the 15-lipoxygenase- I and cyclooxygenase-2 enzymes. UP Kelavkar J Hutzley K Mc Hugh KGD Allen A Parwani, Neoplasia 2009 11 692 699 19568414
16. COX and LOX eicosanoids modulate platelet activation and procoagulation induced by two murine cancer cells. ME Pasqualini CE Mohn JP Petiti AR Eynard, Prost Leukot Essent Fatty Acids 2000 63 377 383 10.1054/plef.2000.0228 (Pubitemid 32096977)
17. Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE: 15-HETE ratio. A possible role of their metastatic potential. ME Pasqualini VL Heyd P Manzo AR Eynard, Prost Leukot Essent Fatty Acids 2003 68 9 16 10.1016/S0952-3278(02)00230-2 (Pubitemid 36197481)
18. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. C Vermmes CP Haanen M Reutelingsperger, J Immunol Methods 1995 180 38 52
19. A novel monoclonal antibody permitting recognition of NKT cells in various mouse strains. H Maruoka K Shinohara M Miyata T Sugimura M Terada H Wakasugi, Biochem Biophys Res Commun 1998 242 413 418 10.1006/bbrc.1997.7676 9446809
20. Generalized weighted additive models based on distribution functions. Y In-Kwon, Statis Probab Lett 2007 77 1394 1402 10.1016/j.spl.2007.03.029
21. Essential Fatty acids a review. UN Das, Curr Pharm Biotechnol 2006 7 467 82 10.2174/138920106779116856 17168664
22. Can essential fatty acids reduce the burden of disease(s)? UN Das, Lipids Health Dis 2008 7 9 27 10.1186/1476-511X-7-9 18348729
23. Polyunsaturated fatty acids (PUFAs) and eicosanoids in human health and pathologies. H Tapiero GN Ba P Coureur KD Tew, Biomed Pharmacol 2000 56 215 222 10.1016/S0753-3322(02)00193-2
24. Prostagalndin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. R Pair B Soreghan IL Szabo M Pavelka D Baatar AS Tarnawski, Nat Med 2002 8 289 293 10.1038/nm0302-289 11875501
25. The role of COX-2 in intestinal inflammation and colorectal cancer. D Wang RN Dubois, Oncogene 2010 29 781 788 10.1038/onc.2009.421 19946329
26. Deciphering macrophage roles in human tumors. C Ruhrberg M De Palma, Nat Med 2010 16 861 862 10.1038/nm0810-861 20689550
27. Stopping macrophages wounds tumors. JE Qualls PJ Murray, Nat Med 2010 16 863 864 10.1038/nm0810-863 20689551
28. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. AH Tashjian Jr EF Voelkel M Lazzaro D Goad T Bosma L Levine, Endocrinology 1987 120 2029 2036 10.1210/endo-120-5-2029 3106013
29. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity. DG Alleva CJ Burger KD Elgert, J Leukoc Biol 1993 53 550 558 8388910
30. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. U Karck T Peters K Decker, J Hepatol 1988 7 352 361 10.1016/S0168-8278(88)80008-4 3148653
31. Modulation of antitumour activity of macrophages by regulation of eicosanoids and cytokine production. S Ben-Efraim IL Bonta, Int J Immunopharmacol 1994 16 397 399 10.1016/0192-0561(94)90027-2 7927985
32. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. BS Chae TY Shin DK Kim JS Eun JY Leem JH Yang, Arch Pharm Res 2008 31 503 510 10.1007/s12272-001-1185-6 18449509
33. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. VJ Palombella J Vilcek, J Biol Chem 1989 264 18128 18136 2808369
34. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. P Suffys R Beyaert F Van Roy W Fiers, Biochem Biophys Res Commun 1987 149 735 743 10.1016/0006-291X(87)90429-3 3122740
35. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. P Suffys R Beyaert D De Valck B Vanhaesebroeck F Van Roy W Fiers, Eur J Biochem 1991 195 465 475 10.1111/j.1432-1033.1991.tb15727.x 1847684
36. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. ML Neale RA Fiera N Matthews, Immunology 1988 64 81 85 3133309
37. Regulation by dietary essential fatty acid balance of tumor necrosis factor production in mouse macrophages. S Watanabe K Onozaki S Yamamoto H Okuyama, J Leukoc Biol 1993 53 151 156 7680370
38. Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages. PS Tappia WJ Man RF Grimble, Mol Cell Biochem 1995 143 89 98 10.1007/BF01816941 7596352
39. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. GS Kumar UN Das, Prostaglandins Leukot Essent Fatty Acids 1994 50 331 334 10.1016/0952-3278(94)90242-9 7938085
40. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. UN Das, Cancer Lett 1991 56 235 243 10.1016/0304-3835(91)90008-6 1850658
41. Local application of gamma-linolenic acid in the treatment of human gliomas. UN Das VV Prasad DR Reddy, Cancer Lett 1995 94 147 155 10.1016/0304-3835(95)03844-M 7634242
42. 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. RR Nazarewicz WJ Zenebe A Parihar MS Parihar M Vaccaro C Rink CK Sen P Ghafourifar, Arch Biochem Biophys 2007 468 114 20 10.1016/j.abb.2007.09.018 17963719
43. Essential fatty acids, lipid peroxidation and apoptosis. UN Das, Prostaglandins Leukot Essen Fatty Acids 1999 61 157 63 10.1054/plef.1999.0085 (Pubitemid 29520805)
44. Diet, Nutrition, and the life-course approach to cancer prevention. R Uauy N Solomons, J Nutr 2005 135 2934S 2945S 16382507
45. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. X Zuo Y Wu JS Morris JB Stimmel LM Leesnitzer SM Fischer SM Lippman I Shureiqi, Oncogene 2006 25 1225 1241 10.1038/sj.onc.1209160 16288226
46. Mechanisms regulating tumour angiogenesis by 12-lipoxygenase in prostate cancer cells. D Nie S Krishnamoorthy R Jin K Tang Y Chen Y Qiao A Zacharek Y Guo J Milanini G Pages KV Honn, J Biol Chem 2006 281 18601 18609 10.1074/jbc.M601887200 16638750
47. 15(S)-Hydroxyeicosatetraenoic Acid-Induced Angiogenesis Requires STAT3-Dependent Expression of VEGF. K Srivastava V Kundumani-Sridharan B Zhang AK Bajpai GN Rao, Cancer Res 2007 67 4328 4336 10.1158/0008-5472.CAN-06-3594 17483346